WuXi is considering the sale of some US and European operations to mitigate the impact of upcoming restrictions.

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Two years after the FDA placed partial clinical hold, Avidity can resume research of del-desiran as a treatment for myotonic ...

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults ...

It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical ...

Amidst the long-running Cas9 patent battle, Editas Medicine has struck a deal to sell a portion of its future revenue stream ...

The MediLedger Project utilises blockchain technology to tackle counterfeit drugs. The project uses blockchain to track and ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address at ELRIG Drug Discovery 2024 in London, UK.